This update includes:

  • DEA Revises Telemedicine Prescribing Guidelines
  • DEA Statement on COVID-19 Telemedicine Flexibilities
  •  Johns Hopkins Presses CMS to Extend Telehealth Supervision By Residents
  • and notable research and news developments